Mark C. Schneyer, EVP, CFO: Acadia Pharmaceuticals ACAD Sell · Filed 23/11/21

Trade details

Type: Insider sale
Amount: $115,645.12
Shares · price: 5,108 sh · $22.64 a share
Held after: 20,486 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Mark C. SchneyerEVP, CFO
Trade date: 23/11/20
Filed: 23/11/21
Days to filing: 1 days

Sold 20.0% of holdings

Share of holding sold: 20.0%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 23/10/21~23/12/20

Mark C. Schneyer's recent trades

Mark C. SchneyerEVP, CFO
Planned sale10b5-1 planAcadia Pharmaceuticals
Planned sale10b5-1 plan
Acadia Pharmaceuticals
ACAD
$158.8K
5,849 sh
$158.8K
Filed 08/05
Traded 08/05
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$76.4K
3,506 sh
$76.4K
Filed 05/05
Traded 05/04
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$60.1K
2,709 sh
$60.1K
Filed 04/07
Traded 04/07
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$89.7K
4,177 sh
$89.7K
Filed 03/26
Traded 03/25
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$68.7K
3,171 sh
$68.7K
Filed 03/26
Traded 03/26

Mark C. Schneyer, CFO — sold $115.6K of Acadia Pharmaceuticals ACAD · 20.0% of holdings | Whalegun